 REHOVOT, Israel, Feb. 24, 2021 GLOBE NEWSWIRE -- Kamada Ltd. NASDAQ TASE: KMDA, a plasma-derived biopharmaceutical company, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2020, with the U.S. Securities and Exchange Commission the SEC. 